Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment and Fatigue After Mild to Moderate COVID-19 - Relation to Biomarkers and Neuronal Network Functions

NCT06042530 is registered in ClinicalTrials.gov with Danderyd Hospital as lead sponsor.

NCT NCT06042530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06042530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment and Fatigue After Mild to Moderate COVID-19 - Relation to Biomarkers and Neuronal Network Functions
Lead sponsor
Danderyd Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2021
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, fatigue, mental, post covid-19 condition